Latest BioInvent News & Updates

See the latest news and media coverage for BioInvent. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
BioInvent

Clinical-stage biopharmaceutical company developing antibody-based cancer therapies

bioinvent.com
Headquarters
Lund, Sweden
Company type
Public company
Number of employees
125–200
Industry
Pharmaceuticals

Last updated

Latest news about BioInvent

In short: BioInvent secured FDA Fast Track for BI-1808 and reported strong clinical results for its cancer pipeline despite widening financial losses.

Company announcements

BioInvent

BioInvent's BI-1206 triplet achieves 83% response rate in refractory NHL

The combination showed 81% ORR in follicular lymphoma and lower serious adverse events (14%) versus SOC regimens.

Unlock all announcements with a

Media coverage

Dagens industri

Bioinvent gets fast track from FDA

Bioinvent has been granted fast track status for BI-1808 by the U.S. Food and Drug Administration (FDA), for the treatment of ovarian cancer in combination...

The Globe and Mail

BioInvent’s BI-1206 Triplet Delivers Strong Efficacy and Safety in Refractory NHL

Detailed price information for Bioinvent International Ab (BOVNF) from The Globe and Mail including charting and trades.

Unlock all articles with a

Never miss news about BioInvent

Track BioInvent and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BioInvent competitors & trending companies

Browse news for competitors to BioInvent and other trending companies.